These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37152037)

  • 21. Clinical and Biological Significance of a Necroptosis-Related Gene Signature in Glioma.
    Zhou Z; Xu J; Huang N; Tang J; Ma P; Cheng Y
    Front Oncol; 2022; 12():855434. PubMed ID: 35719998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma.
    Huang J; Xu Z; Teh BM; Zhou C; Yuan Z; Shi Y; Shen Y
    J Clin Lab Anal; 2022 Jun; 36(6):e24480. PubMed ID: 35522142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status.
    Chen C; Wu Y; Chen K; Xia Z; Liu X; Zhang C; Zhao H; Shen A
    Front Genet; 2022; 13():898507. PubMed ID: 35754846
    [No Abstract]   [Full Text] [Related]  

  • 24. Screening and validation of platelet activation-related lncRNAs as potential biomarkers for prognosis and immunotherapy in gastric cancer patients.
    Yuan M; Jia Y; Xing Y; Wang Y; Liu Y; Liu X; Liu D
    Front Genet; 2022; 13():965033. PubMed ID: 36186426
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular Features of Glioma Determined and Validated Using Combined TCGA and GTEx Data Analyses.
    Yang Z; Gong W; Zhang T; Gao H
    Front Oncol; 2021; 11():729137. PubMed ID: 34660294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma.
    Xie Y; Xu Z; Mei X; Shi W
    Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Necroptosis-related lncRNA to establish novel prognostic signature and predict the immunotherapy response in breast cancer.
    Chen F; Yang J; Fang M; Wu Y; Su D; Sheng Y
    J Clin Lab Anal; 2022 Apr; 36(4):e24302. PubMed ID: 35229919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Necroptosis-Associated IncRNAs Signature for Prognosis of Head and Neck Squamous Cell Carcinoma.
    Huang J; Lu R; Zhong D; Weng Y; Liao L
    Front Genet; 2022; 13():907392. PubMed ID: 35754839
    [No Abstract]   [Full Text] [Related]  

  • 29. Development and validation of a prognostic risk signature for lung adenocarcinoma constructed by six ferroptosis, necroptosis, and pyroptosis-related lncRNAs.
    Peng L; Ji J; Zhang C; Wu Z; Sun Y; Fan K; Du W; Liu A; Jiao W
    J Thorac Dis; 2022 Oct; 14(10):3955-3974. PubMed ID: 36389299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N7-methylguanosine-related lncRNAs: Distinction between hot and cold tumors and construction of predictive models in colon adenocarcinoma.
    Cheng Z; Wang J; Xu Y; Jiang T; Xue Z; Li S; Zhao Y; Song H; Song J
    Front Oncol; 2022; 12():951452. PubMed ID: 36185235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
    Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
    Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-talk between necroptosis-related lncRNAs to construct a novel signature and predict the immune landscape of lung adenocarcinoma patients.
    Wu J; Song D; Zhao G; Chen S; Ren H; Zhang B
    Front Genet; 2022; 13():966896. PubMed ID: 36186456
    [No Abstract]   [Full Text] [Related]  

  • 33. Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma.
    Xu Y; Chen Y; Niu Z; Yang Z; Xing J; Yin X; Guo L; Zhang Q; Yang Y; Han Y
    Front Surg; 2022; 9():860806. PubMed ID: 35937602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Necroptosis-Related lncRNA-Based Signature to Predict Prognosis and Probe Molecular Characteristics of Stomach Adenocarcinoma.
    Luo L; Li L; Liu L; Feng Z; Zeng Q; Shu X; Cao Y; Li Z
    Front Genet; 2022; 13():833928. PubMed ID: 35330731
    [No Abstract]   [Full Text] [Related]  

  • 35. A novel necroptosis-related lncRNAs signature effectively predicts the prognosis for osteosarcoma and is associated with immunity.
    Liu B; Feng C; Liu Z; Tu C; Li Z
    Front Pharmacol; 2022; 13():944158. PubMed ID: 36105232
    [No Abstract]   [Full Text] [Related]  

  • 36. Prediction of Prognosis and Immunotherapy of Osteosarcoma Based on Necroptosis-Related lncRNAs.
    Wang G; Zhang X; Feng W; Wang J
    Front Genet; 2022; 13():917935. PubMed ID: 35692813
    [No Abstract]   [Full Text] [Related]  

  • 37. A novel model based on necroptosis-related genes for predicting immune status and prognosis in glioma.
    Yuan YS; Jin X; Chen L; Liao JM; Zhang Y; Yu KW; Li WK; Cao SW; Huang XZ; Kang CM
    Front Immunol; 2022; 13():1027794. PubMed ID: 36389690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a cellular senescence-related-lncRNA (SRlncRNA) signature to predict the overall survival of glioma patients and the tumor immune microenvironment.
    Liu Q; Bao H; Zhang S; Song T; Li C; Sun G; Sun X; Fu T; Wang Y; Liang P
    Front Genet; 2023; 14():1096792. PubMed ID: 36911393
    [No Abstract]   [Full Text] [Related]  

  • 39. Integrated analysis of necroptosis-related genes for evaluating immune infiltration and colon cancer prognosis.
    Yang W; Lu S; Peng L; Zhang Z; Zhang Y; Guo D; Ma F; Hua Y; Chen X
    Front Immunol; 2022; 13():1085038. PubMed ID: 36618366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients.
    He Y; Ye Y; Tian W; Qiu H
    Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.